Positive Bioscience

Positive Bioscience is a leading Indian genomics company that specializes in personal genomics and cancer molecular diagnostics. The company provides high-end genetic testing services designed to predict disease risk and guide personalized treatment strategies for oncology patients. Their flagship platform, PositiveSelect, utilizes next-generation sequencing to analyze tumor DNA and identify optimal targeted therapies. In addition to clinical diagnostics, the company established India's first personal genomics clinic in partnership with Medanta - The Medicity. In 2023, MedGenome acquired the commercial genomics business of Positive Bioscience to strengthen its leadership in the South Asian genetic testing market.